S2-E54.1 - Inside the Patient-Focused Drug Development meeting: Stories of Personal Experiences

Send us Fan MailGlobal Liver Institute Founder, President and CEO Donna Cryer and her fellow patient and patient advocate Terri Milton join Stephen Harrison, Louise Campbell and Roger Green to discuss the ground-breaking NASH Patient-Focused Drug Development meeting held on November 4, 2021 and some personal experiences that made PFDD such a priority.In this conversation, patient and patient advocate Terri Milton shares her 20-year experience with NASH, cirrhosis, HCC (hepatocellular carcinoma) and how related effects like hepatic encephalopathy and the issue of waiting for a liver transplant affect her life. Stephen Harrison laments that he was not Terri's physician and describes the phenomenon of "peak and shriek" when a surgeon opens a patient's midsection and finds previously unknown evidence of cirrhosis. Finally, Louise Campbell discusses the story of Keiron Dyer, a former English national team player currently awaiting a liver transplant for primary sclerosing cholangitis.